Accueil › Cancer du pancréas › Géorgie › Atlanta
Essais cliniques pour Cancer du pancréas à Atlanta, GA
23 études pour Cancer du pancréas recherchent des participants dans et autour de Atlanta (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Recrutement en coursPhase 3
- Piedmont Cancer Institute, Atlanta
- Piedmont Healthcare, Atlanta
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Recrutement en coursPhase 1
- Emory University, Atlanta
Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer
Recrutement en coursPhase 2
- Emory University Hospital/Winship Cancer Institute, Atlanta
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
Recrutement en coursPhase 3
- Piedmont Healthcare, Atlanta
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Recrutement en coursPhase 3
- Piedmont Physicians Medical Oncology Atlanta, Atlanta
- Winship Cancer Institute, Emory University, Atlanta
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Recrutement en coursPhase 3
- Investigative Site US023, Atlanta
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Recrutement en coursPhase 3
- Piedmont Healthcare - Piedmont Physicians Medical Oncology Atlanta, Atlanta
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
Recrutement en coursÉtude observationnelle
- Piedmont Healthcare, Atlanta
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Recrutement en coursPhase 2
- Emory University - Winship Cancer Institute, Atlanta
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
Recrutement en coursÉtude observationnelle
- Emory University Hospital/Winship Cancer Institute, Atlanta
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Recrutement en coursÉtude observationnelle
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Recrutement en coursPhase 1
- Emory University, Atlanta
Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
Recrutement en cours
- Emory University, Atlanta
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Recrutement en coursPhase 1
- Emory University - Winship Cancer Institute, Atlanta
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Recrutement en coursPhase 3
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Piedmont Hospital, Atlanta
- et 2 autres
Pancreatic Cancer Early Detection Consortium
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Emory University Hospital, Atlanta
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Recrutement en coursPhase 2
- Piedmont Healthcare Inc., Atlanta
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Recrutement en coursPhase 3
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
- et 1 autres
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Recrutement en coursPhase 1/2
- Piedmont Healthcare, Atlanta
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Recrutement en coursPhase 2
- Ohio State University-Telemedicine, Atlanta
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Recrutement en coursÉtude observationnelle
- Northside Hospital, Atlanta
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recrutement en coursÉtude observationnelle
- Massive Bio SYNERGY-AI site, Atlanta
Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy
Recrutement en coursÉtude observationnelle
- Emory University Hospital/Winship Cancer Institute, Atlanta
Essais pour Cancer du pancréas dans d'autres villes
- Houston, TX61 études
- New York City, NY60 études
- Boston, MA43 études
- Nashville, TN39 études
- Los Angeles, CA35 études
- St. Louis, MO33 études
- Arlington, VA33 études
- Baltimore, MD31 études
- San Antonio, TX31 études
- Philadelphia, PA26 études
- Tampa, FL26 études
- Durham, NC24 études
Autres études à Atlanta
- Cancer (tous types)49 études
- Cancer du poumon non à petites cellules47 études
- Myélome multiple42 études
- Cancer du sein41 études
- Cancer de la prostate33 études
- Leucémie aiguë myéloïde31 études
- Cancer de l'ovaire29 études
- Cancer colorectal29 études
- Cancer du poumon29 études
- Cancer métastatique28 études
- Trouble dépressif majeur25 études
- Insuffisance cardiaque25 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.